CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,273,643 | -27.8% | 253,028 | -41.4% | 0.40% | -23.9% |
Q2 2023 | $5,919,823 | +1.5% | 431,474 | +68.1% | 0.52% | -5.6% |
Q1 2023 | $5,831,065 | -57.6% | 256,649 | -56.0% | 0.56% | -59.3% |
Q4 2022 | $13,740,675 | +75.3% | 583,716 | +94.2% | 1.36% | +64.6% |
Q3 2022 | $7,839,000 | +130.4% | 300,590 | +94.0% | 0.83% | +141.4% |
Q2 2022 | $3,402,000 | +408.5% | 154,968 | +1597.9% | 0.34% | +614.6% |
Q2 2021 | $669,000 | -39.9% | 9,127 | -44.9% | 0.05% | -52.5% |
Q4 2020 | $1,113,000 | -21.7% | 16,573 | -40.0% | 0.10% | -37.3% |
Q3 2020 | $1,422,000 | -47.5% | 27,632 | -61.5% | 0.16% | -47.9% |
Q2 2020 | $2,707,000 | -33.1% | 71,834 | -47.0% | 0.31% | -49.1% |
Q1 2020 | $4,044,000 | -61.5% | 135,654 | -55.6% | 0.61% | -42.8% |
Q4 2019 | $10,503,000 | +364.7% | 305,578 | +144.6% | 1.06% | +316.1% |
Q3 2019 | $2,260,000 | – | 124,931 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |